Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men**Supported in part by the National Cancer Institute of Canada; Hoechst AG, Frankfurt, West Germany.-Reference-Cited by-同舟云学术

Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men**Supported in part by the National Cancer Institute of Canada; Hoechst AG, Frankfurt, West Germany.

Published:1982-03 Issue:3 Volume:37 Page:416-424
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Faure Nacia,Labrie Fernand,Lemay André,Bélanger Alain,Gourdeau Yves,Laroche Bruno,Robert Gilles

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference26 articles.

1. Studies on prostatic carcinoma. II. The effect of castration on advanced carcinoma of the prostatic gland;Huggins;Arch Surg,1941

2. Veterans Administration Cooperative Urological Research Group: Estrogen treatment for cancer of the prostate;Bailar;Cancer,1970

3. Inhibition of testicular LH/hCG receptor level by treatment with a potent LHRH agonist or hCG;Auclair;Biochem Biophys Res Commun,1977

4. Inhibitory effects of LHRH and its agonists on testicular gonadotropin receptors and spermatogenesis in the rat;Labrie,1978

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pituitary-testis axis dysfunction following adjuvant androgen deprivation therapy;Endocrine-Related Cancer;2023-01-01

2. Basic Principles of Formulation for Biotherapeutics: Approaches to Alternative Drug Delivery;Comprehensive Medicinal Chemistry III;2017

3. Combined blockade of testicular and locally made androgens in prostate cancer: A highly significant medical progress based upon intracrinology;The Journal of Steroid Biochemistry and Molecular Biology;2015-01

4. GnRH agonists and the rapidly increasing use of combined androgen blockade in prostate cancer;Endocrine-Related Cancer;2014-05-13

5. Multicenter clinical trial of leuprolide acetate depot (Luphere depot 3.75 mg) for efficacy and safety in girls with central precocious puberty;Annals of Pediatric Endocrinology & Metabolism;2013